Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for iatrogenic retinal breaks during induction of posterior vitreous detachment in macula surgery.

International ophthalmology·2026
Same author

Sustainable vitreoretinal surgery: balancing environmental responsibility with patient choice.

Eye (London, England)·2026
Same author

Symptom Tracking in Primary Care: Designing and Testing an EHR-Embedded Safety-Net System.

Joint Commission journal on quality and patient safety·2026
Same author

Surgical Management and Outcomes of Large High Myopic Macular Holes: Global Macular Hole Multicenter Study 3.

Retina (Philadelphia, Pa.)·2026
Same author

Nutrition, Cell Signalling, Mitochondrial Function, and Chronic Non-Communicable Disease.

International journal of molecular sciences·2026
Same author

Axial Length Asymmetry in Patients with Unilateral Retinal Detachment.

Medicina (Kaunas, Lithuania)·2026

Related Experiment Video

Updated: Jun 20, 2026

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Revisiting transconjunctival sutureless 25-gauge vitrectomy: still worthwhile?

Teresa Sandinha1, Clairton de Souza, Rohan Essex

  • 1Vitreo-Retina Service, Flinders Eye Centre, Flinders University, Adelaide, Australia. teresa_sandinha@robinsonlloyd.com

Clinical & Experimental Ophthalmology
|October 1, 2009
PubMed
Summary

The sutureless 25-gauge vitrectomy is a safe and effective method for treating various retinal conditions, leading to significant visual improvement. This technique offers fast visual rehabilitation for patients with macular holes, retinal detachments, and diabetic retinopathy.

More Related Videos

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Related Experiment Videos

Last Updated: Jun 20, 2026

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Minimally Invasive Techniques

Background:

  • Vitrectomy is a common surgical procedure for retinal conditions.
  • The 25-gauge (25G) vitrectomy system offers a sutureless approach.
  • Evaluating the outcomes of 25G vitrectomy is crucial for surgical practice.

Purpose of the Study:

  • To assess the efficacy and safety of the sutureless 25-gauge vitrectomy.
  • To analyze visual acuity outcomes and complication rates.
  • To determine the suitability of 25G vitrectomy for diverse retinal pathologies.

Main Methods:

  • Retrospective case review of 232 eyes from 228 patients.
  • Surgery performed between January 2003 and August 2006.
  • Minimum follow-up period of 3 months.

Main Results:

  • Mean visual acuity improved from 0.9 to 0.5 logMAR (P < 0.0001).
  • Highest visual gains observed in rhegmatogenous retinal detachment and diabetic retinopathy cases.
  • Transient hypotony in 9.2%, retinal redetachment in 7.3% (all achieved final success), and endophthalmitis in 0.4%.

Conclusions:

  • Sutureless 25-gauge vitrectomy is a safe and effective surgical option.
  • The technique provides significant and rapid visual rehabilitation.
  • It is suitable for treating a range of retinal conditions including macular hole, retinal detachment, epiretinal membrane, and proliferative diabetic retinopathy.